Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities

被引:20
作者
Baade, Peter D. [1 ,2 ]
Aitken, Joanne F. [1 ,3 ]
Ferguson, Megan [1 ]
Gardiner, Robert A. [4 ,5 ]
Chambers, Suzanne K. [1 ,6 ]
机构
[1] Canc Council Queensland, Viertel Ctr Res Canc Control, Spring Hill, Qld 4004, Australia
[2] Queensland Univ Technol, Sch Publ Hlth, Kelvin Grove, Qld 4059, Australia
[3] Univ Queensland, Sch Populat Hlth, Herston, Qld 4061, Australia
[4] Univ Queensland, Royal Brisbane Hosp, Clin Res Ctr, Herston, Qld 4029, Australia
[5] Univ Queensland, Royal Brisbane Hosp, Dept Urol, Herston, Qld 4029, Australia
[6] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
STAGE BREAST-CANCER; RADIATION-THERAPY; DISTANCE; MORTALITY; MULTILEVEL; MASTECTOMY; CARCINOMA; SURVIVAL; FACILITY; TRENDS;
D O I
10.1186/1471-2407-10-452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Patterns of diagnosis and management for men diagnosed with prostate cancer in Queensland, Australia, have not yet been systematically documented and so assumptions of equity are untested. This longitudinal study investigates the association between prostate cancer diagnostic and treatment outcomes and key area-level characteristics and individual-level demographic, clinical and psychosocial factors. Methods/Design: A total of 1064 men diagnosed with prostate cancer between February 2005 and July 2007 were recruited through hospital-based urology outpatient clinics and private practices in the centres of Brisbane, Townsville and Mackay (82% of those referred). Additional clinical and diagnostic information for all 6609 men diagnosed with prostate cancer in Queensland during the study period was obtained via the population-based Queensland Cancer Registry. Respondent data are collected using telephone and self-administered questionnaires at pre-treatment and at 2 months, 6 months, 12 months, 24 months, 36 months, 48 months and 60 months post-treatment. Assessments include demographics, medical history, patterns of care, disease and treatment characteristics together with outcomes associated with prostate cancer, as well as information about quality of life and psychological adjustment. Complementary detailed treatment information is abstracted from participants' medical records held in hospitals and private treatment facilities and collated with health service utilisation data obtained from Medicare Australia. Information about the characteristics of geographical areas is being obtained from data custodians such as the Australian Bureau of Statistics. Geo-coding and spatial technology will be used to calculate road travel distances from patients' residences to treatment centres. Analyses will be conducted using standard statistical methods along with multilevel regression models including individual and area-level components. Conclusions: Information about the diagnostic and treatment patterns of men diagnosed with prostate cancer is crucial for rational planning and development of health delivery and supportive care services to ensure equitable access to health services, regardless of geographical location and individual characteristics.
引用
收藏
页数:8
相关论文
共 33 条
[1]  
*AHW, 2004, RUR REG REM HLTH GUI
[2]   Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].
Andriole, Gerald L. ;
Grubb, Robert L., III ;
Buys, Saundra S. ;
Chia, David ;
Church, Timothy R. ;
Fouad, Mona N. ;
Gelmann, Edward P. ;
Kvale, Paul A. ;
Reding, Douglas J. ;
Weissfeld, Joel L. ;
Yokochi, Lance A. ;
Crawford, E. David ;
O'Brien, Barbara ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hayes, Richard B. ;
Kramer, Barnett S. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Pinsky, Paul F. ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319
[3]  
[Anonymous], 2010, GLOBOCAN 2008 CANC I
[4]  
[Anonymous], CENS POP HOUS SOC EC
[5]  
[Anonymous], 2003, Australian Social Trends 2003
[6]  
Australian Cancer Network Working Party on Management of Localised Prostate Cancer, 2002, CLIN PRACT GUID EV B
[7]  
Australian Institute of Health and Welfare, 2010, AUSTR HLTH SER AIHW, V12
[8]   Communicating prostate cancer risk: what should we be telling our patients? [J].
Baade, PD ;
Steginga, SK ;
Pinnock, CB ;
Aitken, JF .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (09) :472-475
[9]   A multilevel study of the determinants of area-level inequalities in colorectal cancer survival [J].
Baade, Peter D. ;
Turrell, Gavin ;
Aitken, Joanne F. .
BMC CANCER, 2010, 10
[10]   International epidemiology of prostate cancer: Geographical distribution and secular trends [J].
Baade, Peter D. ;
Youlden, Danny R. ;
Krnjacki, Lauren J. .
MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (02) :171-184